Cuzin B, Giuliano F, Jamin Ch, Legros J-J, Lejeune H, Rigot J-M, Roger M
Service d'Urologie, Hôpital Edouard Herriot, Lyon, France.
Ann Endocrinol (Paris). 2003 Oct;64(4):289-304.
There is increasing interest in the subject of hormone changes in the aging male, which is likely to become particularly important with the expected growth in the population of men over 50. The main concerns at present are androgen decline in the aging male (ADAM), or partial androgen deficiency of the aging male (PADAM), commonly known as the andropause. Although there have been advances in our knowledge of androgen deficiency in the aging male, it is still incomplete, sometimes confusing, and some aspects of androgen replacement therapy remain controversial. The International Society for the Study of the Aging Male (ISSAM) therefore felt it was a good time to review the current situation by publishing a series of practical and official guidelines concerning the diagnosis, treatment and monitoring of late-onset hypogonadism in males. The aim of this study is to present the French translation of these recent international guidelines, and to comment on them.
人们对老年男性激素变化这一主题的兴趣与日俱增，随着预计50岁以上男性人口的增长，这一主题可能会变得尤为重要。目前主要关注的是老年男性雄激素缺乏症（ADAM），即老年男性部分雄激素缺乏症（PADAM），通常称为男性更年期。尽管我们对老年男性雄激素缺乏症的认识已有进展，但仍不完整，有时还令人困惑，雄激素替代疗法的某些方面仍存在争议。因此，国际老年男性研究学会（ISSAM）认为现在是通过发布一系列关于男性迟发性性腺功能减退的诊断、治疗和监测的实用官方指南来审视当前情况的好时机。本研究的目的是呈现这些最新国际指南的法语译文，并对其进行评论。
